Kovack Advisors, Inc. Elanco Animal Health Inc Transaction History
Kovack Advisors, Inc.
- $985 Million
- Q4 2024
A detailed history of Kovack Advisors, Inc. transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Kovack Advisors, Inc. holds 14,060 shares of ELAN stock, worth $161,971. This represents 0.02% of its overall portfolio holdings.
Number of Shares
14,060Holding current value
$161,971% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding ELAN
# of Institutions
445Shares Held
474MCall Options Held
4.62MPut Options Held
753K-
Dodge & Cox San Francisco, CA83.3MShares$960 Million0.74% of portfolio
-
Primecap Management CO Pasadena, CA52.6MShares$606 Million0.58% of portfolio
-
Vanguard Group Inc Valley Forge, PA48.9MShares$564 Million0.01% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$268 Million0.01% of portfolio
-
Black Creek Investment Management Inc. Toronto, A621.3MShares$245 Million11.09% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $5.46B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...